🔎 Trials Near Me

Home › Follicular Lymphoma › Massachusetts

Pag-aaral pangklinika para sa Follicular Lymphoma sa Massachusetts

19 pag-aaral para sa Follicular Lymphoma ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma and Marginal Zone Lymphoma Not Accomplishing a Complete Response With Upfront Therapy

  • Beth Israel Deaconess Medical Center, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06510361

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

  • Beth Israel Deaconess Medical Center, Boston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06091254

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07101328

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07226843

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

  • Tufts Medical Center, Boston
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07215910

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

  • Research Site, Boston
  • Research Site, Boston
Nagre-recruitPhase 3
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT06549595

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT05303519

CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma

  • Massachusetts General Hospital, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06026319

Emapalumab Prevention of CAR-T Cell Associated Toxicities

  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT06550141

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Dana Farber Cancer Institute, Boston
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT05006716

Epco, Zanu, Ritux for R/R FL or MZL

  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06563596

NEO100 and High-Grade Meningioma

  • Tufts Medical Center, Boston
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05023018

Epcoritamab and Rituximab for First-line Follicular Lymphoma

  • Beth Israel Deaconess Medical Center, Boston
  • Dana-Farber Cancer Institute, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT05783609

A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investigator's Choice in Participants With Relapsed/Refractory Follicular Lymphoma Who Have Received at Least 1 Prior Line of Systemic Therapy (GOLSEEK-4)

  • Local Institution - 0145, Boston
  • Local Institution - 0244, Boston
  • Local Institution - 0247, Boston
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT06911502

Odronextamab in Low Tumor Volume Advanced FL

  • Beth Israel Deaconess Medical Center, Boston
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 13, 2026 · NCT07128641

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Beth Israel Deaconess Medical Center, Boston
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 13, 2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • University of Massachusetts Memorial Medical Center, Worcester
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 10, 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Worcester
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

  • Shwachman-Diamond Syndrome Alliance Inc., Woburn
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update May 31, 2025 · NCT06999954

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.